Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 5Cohance Lifesciences
02 32care4
03 9ANI Pharmaceuticals Inc
04 2Abbott Laboratories
05 5Actavis Inc
06 3AiPing Pharmaceutical Inc
07 2Ajanta Pharma Limited
08 4Alphapharm PTY Ltd
09 2Annora Pharma
10 9Apotex Inc
11 4Arrow Pharmaceuticals
12 1Aspire Lifesciences Pvt Ltd
13 3Avet Pharmaceuticals
14 8BGP Group of Companies
15 2BGP PHARMA ULC
16 5Bionpharma
17 3Chartwell Pharmaceuticals llc
18 2EG SpA
19 2EG Spa
20 1Generis Farmaceutica SA
21 2JV Healthcare Limited
22 5Jazz Pharmaceuticals
23 2NM Pharma Limited
24 1ORIFARM GROUP AS
25 1Oethmaan Biosims
26 2PH HEALTH
27 2Pharmascience Inc.
28 3Quagen Pharma
29 2STADA Arzneimittel
30 3Sandoz B2B
31 2Smith & Kenner Pharmaceuticals
32 4Solvay Chemicals International S.A
33 3Sun Pharmaceutical Industries Limited
34 3Synthon Pharmaceuticals
35 5Teva Pharmaceutical Industries
36 2Torrent Pharmaceuticals Limited
37 2Unimedic AB
38 3Upsher-Smith Laboratories
39 20Viatris
40 4WAGNER PHARMACEUTICALS PTY LTD
41 1Wockhardt UK
01 4Antic-calc Tablet, Film Coated
02 14CAPSULE, EXTENDED RELEASE;ORAL
03 2Capsule
04 22Film Coated Tablet
05 8Film-Coated Tablets
06 4Fluvoxamine 100Mg 30 Joined' Oral Use
07 4Fluvoxamine 50Mg 30 Joined' Oral Use
08 1Pellets
09 4TAB
10 8TABLET
11 3TABLET; ORAL
12 48TABLET;ORAL
13 5Tablet
14 20tablet
01 2Allowed
02 2Approved
03 6Authorised
04 4Authorized
05 40DISCN
06 6Deregistered
07 3Generic
08 1Originator
09 8Prescription
10 22RX
11 2Withdrawn
12 51Blank
01 2APO-FLUVOXAMINE
02 4APO-Fluvoxamine
03 2DUMIROX
04 4Dumirox
05 2Dumyrox
06 2FEVARIN
07 2FLUVOXAMINE EG
08 53FLUVOXAMINE MALEATE
09 4FLUVOXAMINE-WGR
10 2Farin
11 4Faverin
12 3Faverin 100
13 2Faverin 50
14 10Fevarin
15 1Floxifral
16 1Floxifral junior
17 2Fluvosol
18 1Fluvoxamina Generis
19 2Fluvoxamina Sandoz
20 3Fluvoxamine
21 1Fluvoxamine 100 Oethmaan
22 1Fluvoxamine- Hexal
23 12LUVOX
24 2LUVOX CR
25 4Luvox
26 1Luvox 100
27 2MAVERAL
28 2Maveral
29 2Movox 100
30 2Movox 50
31 2PMS-FLUVOXAMINE
32 2TEVA-FLUVOXAMINE
33 8Blank
01 20Australia
02 8Canada
03 8India
04 16Italy
05 8Malta
06 4Norway
07 4South Africa
08 4Spain
09 8Sweden
10 2Switzerland
11 65USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2007-12-20
Application Number : 21519
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2007-12-20
Application Number : 21519
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2007-12-20
Application Number : 21519
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX CR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-02-28
Application Number : 22033
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX CR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-02-28
Application Number : 22033
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET; ORAL
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number : 22235
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET; ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 22235
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET; ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 22235
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-05
Application Number : 20243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-05
Application Number : 20243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-05
Application Number : 20243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-05
Application Number : 20243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FLUVOXAMINE MALEATE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2001-01-05
Application Number : 75887
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FLUVOXAMINE MALEATE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2001-01-05
Application Number : 75887
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FLUVOXAMINE MALEATE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2001-01-05
Application Number : 75887
Regulatory Info : DISCN
Registration Country : USA
